Thyroid hormone technology - BTGAlternative Names: T3 hormone technology
Latest Information Update: 16 Jul 2016
At a glance
- Originator BTG
- Class Thyroid hormones
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Cardiovascular disorders; Myocardial infarction
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Myocardial-infarction in USA (IV)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Cardiovascular-disorders in USA
- 17 May 2006 Preclinical trials in Cardiovascular disorders in USA (unspecified route)